ARTELO BIOSCIENCES, INC. (ARTL)
About ARTELO BIOSCIENCES, INC.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$12.9M
- Total assets
- $2.8M
- Market cap
- $4.8M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $10.1M
- Operating income
- -$10.1M
- Income tax
- $0
- Net income
- -$9.8M
- EPS (diluted)
- $-3.05
Balance sheet
- Total assets
- $4.7M
- Current assets
- $2.6M
- Total liabilities
- $1.8M
- Current liabilities
- $1.8M
- Shareholders’ equity
- $2.9M
Cash flow
- Operating cash flow
- -$8.3M
- Investing cash flow
- $7.8M
- Financing cash flow
- $112.0K
- Net cash flow
- -$477.0K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $4.8M
- EPS (diluted)
- $-3.05
- Shares outstanding
- 4.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 13, 2015
Artelo Biosciences, Inc. (ARTL) Stock Price
- Reported a net loss of $12.9M.
- Trading 99% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ARTELO BIOSCIENCES, INC..
Write a review
News about ARTELO BIOSCIENCES, INC.
News & sentiment via Polygon.io
Artelo Biosciences, Inc.: frequently asked questions
Is Artelo Biosciences, Inc. an American company?
Artelo Biosciences, Inc. is a US-based company headquartered in Solana Beach, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Artelo Biosciences, Inc. headquartered?
Artelo Biosciences, Inc. is headquartered in Solana Beach, California, United States.
Is Artelo Biosciences, Inc. publicly traded?
Yes — Artelo Biosciences, Inc. is a publicly traded company. Its stock trades under the ticker symbol ARTL on the NASDAQ.
What does Artelo Biosciences, Inc. do?
Artelo Biosciences, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
